Cargando…
Comparative assessment of dexmedetomidine and butorphanol for attenuation of etomidate-induced myoclonus: A double-blind, randomised controlled study
BACKGROUND AND AIMS: Etomidate is a popular induction agent, but its use is associated with myoclonus in 50%–80% of non-premedicated patients. This study aims to compare dexmedetomidine and butorphanol for their relative efficacy in preventing etomidate-induced myoclonus. METHODS: This randomised st...
Autores principales: | Rautela, Rajesh S., Gulabani, Michell, Kumar, Pramod, Salhotra, Rashmi, Mohta, Medha, Verma, Kshitiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566664/ https://www.ncbi.nlm.nih.gov/pubmed/37829775 http://dx.doi.org/10.4103/ija.ija_414_23 |
Ejemplares similares
-
Effect of butorphanol on etomidate-induced myoclonus: a systematic review and meta-analysis
por: Hua, Jun, et al.
Publicado: (2019) -
Butorphanol effectively prevents etomidate-induced myoclonus: a pooled analysis of 788 patients
por: Zhu, Yu, et al.
Publicado: (2018) -
Pretreatment with dexmedetomidine and magnesium sulphate in prevention of etomidate induced myoclonus – A double blinded randomised controlled trial
por: Ghodki, Poonam S, et al.
Publicado: (2021) -
Effect of dexmedetomidine on etomidate-induced myoclonus: a randomized, double-blind controlled trial
por: Miao, Shuai, et al.
Publicado: (2019) -
Prevention of etomidate-induced myoclonus during anesthetic induction by
pretreatment with dexmedetomidine
por: Luan, H.F., et al.
Publicado: (2014)